Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab Long-term Extension in Japanese Psoriasis
NCT00647400Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Apr 2006
- Primary completion
- Sep 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab in plaque psoriasis, sponsored by Abbott Laboratories. Started Apr 2006; status: completed.
02
Drugs
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00647400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00647400.